Insilico's AI-powered robotics lab is a key part of the Company's end-to-end Pharma.AI platform for drug discovery and development. The lab is capable of performing cell culture, high throughput screening, next generation sequencing, cell imaging, and genomics analysis and prediction autonomously.

Here, Insilico Medicine founder and CEO Alex Zhavoronkov, PhD, shows how these "smart" robots can even be trained to dance.